Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous arterial aortoiliac intervention.

F G St Goar1, J D Joye, J R Laird

  • 1Cardiovascular Institute, El Camino Hospital, 2660 Grant Road, Mountain View, CA 94040, USA.

Journal of Interventional Cardiology
|June 11, 2002
PubMed
Summary

Endovascular stenting and balloon angioplasty offer a lower-risk alternative to traditional vascular surgery for aortoiliac disease. These evolving endovascular interventions are becoming preferable due to lower complication rates and acceptable outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated calcium burden measurement in internal carotid artery plaque with CT: a hierarchical adaptive approach.

International angiology : a journal of the International Union of Angiology·2015
Same author

Femoropopliteal in-stent restenosis: current treatment strategies.

The Journal of cardiovascular surgery·2014
Same author

The role of stent-grafts for prevention and treatment of restenosis.

The Journal of cardiovascular surgery·2010
Same author

Excimer laser assisted angioplasty for complex infrainguinal peripheral artery disease: a 2008 update.

The Journal of cardiovascular surgery·2008
Same author

Excimer laser assisted angioplasty for the treatment of critical limb ischemia.

The Journal of cardiovascular surgery·2004
Same author

Mechanism of lumen enlargement with direct stenting versus predilatation stenting: influence of remodelling and plaque characteristics assessed by volumetric intracoronary ultrasound.

Heart (British Cardiac Society)·2002

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortoiliac Disease Treatment

Background:

  • Reconstructive vascular surgery, specifically aortobifemoral bypass, has been a primary treatment for obliterative aortoiliac disease.
  • Surgical interventions yield 5-year patency rates of 85-90% and 10-year rates of 70-75%, with operative mortality of 1.6-3.3% and systemic morbidity of 8.3%.
  • Traditional indications are limited to severe claudication and limb-threatening ischemia due to significant procedural risks.

Purpose of the Study:

  • To evaluate the evolving role of endovascular techniques in treating aortoiliac disease.
  • To compare the risks and benefits of percutaneous interventions versus traditional surgical reconstruction.
  • To explore expanded indications for endovascular treatment of aortoiliac occlusive disease.

Main Methods:

Related Experiment Videos

  • Review of outcomes for balloon angioplasty and endovascular stenting in aortoiliac disease.
  • Comparison of percutaneous intervention data with historical surgical outcomes.
  • Analysis of evolving technologies and limited randomized studies in endovascular aortoiliac interventions.

Main Results:

  • Endovascular stenting and balloon angioplasty are effective modalities for aortoiliac disease, offering lower risk compared to surgery.
  • These less invasive procedures allow for broader indications beyond severe ischemia.
  • Predictable outcomes and acceptable secondary patency rates support the preference for percutaneous interventions.

Conclusions:

  • Endovascular interventions are increasingly preferred over traditional surgery for aortoiliac disease due to lower complication rates.
  • Evolving endovascular technologies are expanding treatment options and improving outcomes.
  • Percutaneous approaches offer a safer alternative when outcomes are predictable and secondary patency is acceptable.